268 related articles for article (PubMed ID: 33277592)
1. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
[TBL] [Abstract][Full Text] [Related]
2. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
3. Grape Seed Proanthocyanidin Extract Ameliorates Streptozotocin-induced Cognitive and Synaptic Plasticity Deficits by Inhibiting Oxidative Stress and Preserving AKT and ERK Activities.
Gao WL; Li XH; Dun XP; Jing XK; Yang K; Li YK
Curr Med Sci; 2020 Jun; 40(3):434-443. PubMed ID: 32681248
[TBL] [Abstract][Full Text] [Related]
4. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology.
Akhtar A; Bishnoi M; Sah SP
Brain Res Bull; 2020 Nov; 164():83-97. PubMed ID: 32784004
[TBL] [Abstract][Full Text] [Related]
5. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.
Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP
Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080
[TBL] [Abstract][Full Text] [Related]
6. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
Shi L; Zhang Z; Li L; Hölscher C
Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
[TBL] [Abstract][Full Text] [Related]
7. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.
Gao C; Liu Y; Jiang Y; Ding J; Li L
Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
[TBL] [Abstract][Full Text] [Related]
9. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
[TBL] [Abstract][Full Text] [Related]
10. Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways.
Salem MA; Budzyńska B; Kowalczyk J; El Sayed NS; Mansour SM
Toxicol Appl Pharmacol; 2021 Oct; 429():115697. PubMed ID: 34428446
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
[TBL] [Abstract][Full Text] [Related]
13. Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease.
Wang CM; Liu MY; Wang F; Wei MJ; Wang S; Wu CF; Yang JY
Pharmacol Biochem Behav; 2013 May; 106():57-67. PubMed ID: 23541491
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.
Hasan N; Zameer S; Najmi AK; Parvez S; Akhtar M
Neurotox Res; 2022 Apr; 40(2):432-448. PubMed ID: 35192144
[TBL] [Abstract][Full Text] [Related]
15. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.
Zhao HL; Cui SY; Qin Y; Liu YT; Cui XY; Hu X; Kurban N; Li MY; Li ZH; Xu J; Zhang YH
J Ethnopharmacol; 2021 Apr; 269():113725. PubMed ID: 33352241
[TBL] [Abstract][Full Text] [Related]
17. Pseudoginsenoside-F11 attenuates cognitive impairment by ameliorating oxidative stress and neuroinflammation in d‑galactose-treated mice.
Zhang Z; Yang H; Yang J; Xie J; Xu J; Liu C; Wu C
Int Immunopharmacol; 2019 Feb; 67():78-86. PubMed ID: 30537634
[TBL] [Abstract][Full Text] [Related]
18. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats.
Yang W; Ma J; Liu Z; Lu Y; Hu B; Yu H
Neurol Sci; 2014 May; 35(5):741-51. PubMed ID: 24337945
[TBL] [Abstract][Full Text] [Related]
19. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
[TBL] [Abstract][Full Text] [Related]
20. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance.
Akhtar A; Dhaliwal J; Sah SP
Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
